| Title: | Circulating transthyretin with atrial morpho-functional phenotypes and atrial fibrillation risk, and the modifying role of BMI |
| Journal: | BMC Medicine |
| Published: | 14 Oct 2025 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/41088066/ |
| DOI: | https://doi.org/10.1186/s12916-025-04391-6 |
| URL: | https://bmcmedicine.biomedcentral.com/counter/pdf/10.1186/s12916-025-04391-6 |
Publication 19180
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BackgroundLow circulating transthyretin (TTR) concentration has been suggested as a biomarker of transthyretin tetramer instability, a prerequisite for the development of transthyretin cardiac amyloidosis. This study aimed to evaluate the associations between circulating TTR levels with incident atrial fibrillation (AF) and other arrhythmias.MethodsThis study used data from the UK Biobank. Participants with available TTR data and without prior arrhythmias were included. The primary outcome was new-onset AF. The secondary outcomes were new-onset supraventricular arrhythmias (SVA), bradyarrhythmias, cardiac block, and ventricular arrhythmias (VA). Multivariable Cox regression was applied to evaluate the associations between circulating TTR levels with arrhythmia outcomes.ResultsA total of 40,723 participants (mean age 56.7 ± 8.2 years; 55% women) were included. After adjusting for potential confounders, one standard deviation (SD) decrease in TTR levels was associated with an increased risk of incident AF (HR 1.06, 95% CI 1.02-1.11). Furthermore, significant associations between low TTR with atrial structural remodeling were observed, manifesting as increased left atrial volume index (β 0.51, 95% CI 0.09-0.92) and right atrial volume index (β 0.87, 95% CI 0.39-1.40). In addition, there was a significant association between lower TTR levels with higher incident SVA risk, but not for bradyarrhythmias, cardiac block, or VA. A consistently significant interaction effect was identified between TTR levels and BMI for the risk of AF, SVA, bradyarrhythmias, and cardiac block (all Pinteraction < 0.05), with lower TTR levels being significantly associated with a higher risk of AF (HR 1.15, 95% CI 1.06-1.26), SVA (HR 1.15, 95% CI 1.06-1.25), bradyarrhythmias (HR 1.17, 95% CI 1.05-1.30), and cardiac block (HR 1.15, 95% CI 1.02-1.29) among individuals with a BMI < 25 kg/m2. In addition, carriers of likely pathogenic or pathogenic TTR variants (LP/P) had lower levels of plasma TTR compared with noncarriers, as well as higher arrhythmia risks, especially for non-Val142Ile carriers.ConclusionsLower circulating TTR concentrations were associated with higher risk of incident AF. Exposure to low TTR and low BMI may be associated with a higher risk of AF, SVA, bradyarrhythmias, and cardiac block.Graphical AbstractLow circulating transthyretin levels predict incident AF. Abbreviations: TTR, transthyretin; AF, atrial fibrillation; SVA, supraventricular arrhythmias; VA, ventricular arrhythmias</p>
14 Keywords
- Adult
- Aged
- Atrial Fibrillation
- Biomarkers
- Body Mass Index
- Female
- Heart Atria
- Humans
- Male
- Middle Aged
- Phenotype
- Prealbumin
- Risk Factors
- United Kingdom
10 Authors
- Nan Zhang
- Ziheng Jia
- Jinhua Zhao
- Xuyao Han
- Jie Liu
- Gary Tse
- Jiandong Zhou
- Kang-Yin Chen
- Gregory Y. H. Lip
- Tong Liu
1 Application
| Application ID | Title |
|---|---|
| 79146 | Development of the predictive risk models for cardiovascular diseases using a multimodality approach |
Enabling scientific discoveries that improve human health